Abstract

Transdermal Gels in the Treatment of Diabetic Neuropathy

Author(s): Hodges Caroline J, Jones Thomas H, Willoughby David L

Issue: Mar/Apr 2000 - Compounding for Diabetes Patients

Page(s): 91-93

Download in electronic PDF format for $75
  • Transdermal Gels in the Treatment of Diabetic Neuropathy Page 1
  • Transdermal Gels in the Treatment of Diabetic Neuropathy Page 2
  • Transdermal Gels in the Treatment of Diabetic Neuropathy Page 3

Abstract

Diabetic neuropathy refers to a large number of clinical syndromes affecting both the autonomic and peripheral nervous systems and both type 1 and type 2 diabetes patients. In this article, the authors place particular emphasis on the use of ketamine Pluronic lecithin organogels for treating diabetic neuropathy. They also discuss the etiology of diabetic neuropathy, its clinical presentation, pain management (glycemic control, tricyclic antidepressants, anticonvulsants, ketamine and autonomic agents) and provide three brief case reports describing the use of a polymedicine formula . They conclude that medications administered by transdermal gels are a viable option and potentially the most rewarding for a compounding pharmacist, as they allow pain relief with fewer adverse effects. The real challenge is deciding whether the patient should begin with the polymedicine formula or with ketamine 10% and amitriptyline 2%, with additional ingredients added as needed to determine the optimal combination of medications for analgesic effects. More research is needed to determine the best combination of agents.

Related Keywords

  • diabetic neuropathy
  • burning pain
  • allodynia
  • hyperpathia
  • glycemic control
  • tricyclic antidepressants
  • gabapentin
  • ketamine
  • NMDA receptor antagonist
  • phantom limb pain
  • clonidine
  • baclofen

Related Categories

  • DIABETES
  • WOUND CARE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2000
Pg. 91-93
Transdermal Gels in the Treatment of Diabetic Neuropathy
Author(s): Hodges Caroline J, Jones Thomas H, Willoughby David L
Jan/Feb 2003
Pg. 21-23
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Author(s): Vail Jane
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Jan/Feb 2000
Pg. 6-15
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Author(s): Jones Marty
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jul/Aug 2004
Pg. 265-267
Case Report: Wound Care of a Diabetic Foot Ulcer
Author(s): Wynn Tom
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
Mar/Apr 2024
Pg. 135
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 231
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Author(s): Allen Loyd V Jr
Sep/Oct 2005
Pg. 339-346
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Author(s): Mishkan Emilyn S
May/Jun 2007
Pg. 181-184
Transdermal Gel in the Treatment of Postoperative Pain
Author(s): Alexander Kayla, Wynn Tom
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 111-116
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024
Pg. 131
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 157
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Author(s): Allen Loyd V Jr